Try our Advanced Search for more refined results
USA v. Babich et al
Case Number:
1:16-cr-10343
Court:
Nature of Suit:
Judge:
Firms
- Clark Hill
- Donnelly Conroy
- Fick & Marx
- Fitch Law Partners
- Hogan Lovells
- King & Spalding
- Kobre & Kim
- Miner Siddall
- Morgan Lewis
- Nixon Peabody
- Ropes & Gray
- Weil Gotshal
- White & Case
- Wilkinson Stekloff
Companies
Sectors & Industries:
-
January 13, 2020
Insys Judge Wonders If Potential Punishment Is Too Harsh
The Massachusetts federal judge overseeing the case of seven former Insys Therapeutics Inc. executives convicted in an opioid kickback scheme said Monday that the lengthy sentencing guidelines and the government's $306 million dollar restitution ask may be too severe for the conduct at issue.
-
January 06, 2020
Insys Execs Say Restitution Should Be $18.4M, Not $306M
Seven former Insys Therapeutics Inc. executives on Monday told a Massachusetts federal judge to disregard the government's bid for $306 million in restitution related to an opioid kickback scheme, saying restitution should be limited to $18.4 million.
-
December 19, 2019
Feds Want 15 Years For Convicted Insys Founder
Federal prosecutors say Insys' founder should spend 15 years in prison after being convicted of bribing doctors to prescribe opioids, the longest recommended term in a spate of sentencing memoranda countered by bids for a year or less in jail from the founder and six others.
-
December 13, 2019
Feds Press For Massive $306M Restitution In Insys Exec Trial
Seven former Insys Therapeutics Inc. executives who were either convicted or copped a plea in connection with an opioid kickback scheme should be on the hook for more than $300 million in restitution to defrauded insurance companies and a handful of patients, the government said Friday.
-
November 27, 2019
Insys Verdict Flip Is A Check On Aggressive Feds
Insys Therapeutics Inc. executives got part of the landmark opioid verdict against them thrown out, showing overreach by Boston federal prosecutors as well as the high bar of evidence needed to prove a conspiracy to distribute legal drugs, experts told Law360.
-
November 26, 2019
Insys Judge Drops Part Of Landmark Opioid Verdict
The Massachusetts federal judge overseeing the Insys Therapeutics Inc. racketeering trial struck down Tuesday part of the verdict in the first successful prosecution against a drugmaker tied to the opioid crisis, although she denied the company's bid for a new trial.
-
November 18, 2019
Judge Caps Insys Exec's 'Astronomical' Nixon Peabody Tab
A Massachusetts federal judge on Monday said the convicted founder of Insys Therapeutics Inc. will only be allowed $300,000 to pay a legal bill she called "astronomical" from Nixon Peabody LLP to defend him in 200 civil suits ahead of his criminal sentencing in January.
-
October 17, 2019
Insys Exec Trial Fair Despite Alleged Weil Conflict, Judge Says
A convicted former Insys Therapeutics Inc. executive "got a fair trial" despite Weil Gotshal & Manges LLP representing him during his criminal trial while guiding the company through its bankruptcy, a federal judge said following a fiery Thursday afternoon hearing over the alleged conflict.
-
October 16, 2019
Insys Judge Unsure If Execs' Bribes Equal Drug Dealing
A federal judge has expressed skepticism about part of the theory used to convict five former Insys Therapeutics Inc. executives of bribing doctors to prescribe opioids, wondering whether an indifference to who received the powerful painkiller equated to conspiring with doctors to deal drugs to patients who didn't need them.
-
September 17, 2019
Weil Was Upfront About Repping Insys In Ch. 11, Atty Says
Weil Gotshal & Manges LLP was upfront with a former Insys Therapeutics Inc. executive when the firm was also called upon to represent his former company in bankruptcy proceedings, a firm partner said Monday in an affidavit, pushing back on the executive's claim that he was in the dark about the potential conflict.